Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide)
- Environmental Clearance CPCB Quick Guide for Exporters
- DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders
- Key DGFT Changes 2025: Advance Licensing, EPCG & EPR Overview
- DGFT 2025 Updates: Key Changes for Advance Authorization License & EPCG Authorization Licence Holders
- DGFT Notifies 3 New SIONs: A-3690, A-3691 & A-3692
- DGFT allocates 5841 MT for Sugar Export
- DGFT Eases Export Rules for Pharma Grade Sugar – Key Changes in ANF-2N Form
FeATURED ARTICLES
Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide) Exporting in India can feel like a legal…
Environmental Clearance CPCB: Quick Guide for Exporters If you’re an Indian exporter or manufacturer working under schemes like the Advanced…
DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders The Directorate General of Foreign Trade (DGFT) has…
Key DGFT Changes 2025: Advance Licensing, EPCG & EPR Overview DGFT Updates 2025: What Exporters and Importers Should Know About…
